High-risk neuroblastoma is characterized by tumor cell dissemination into the bone marrow, organ metastasis, amplification of the MYCN oncogene (in 40% of cases, personal communication Ladenstein R. and Pötschger U.)and recurrent segmental chromosomal aberrations [3–6]. The gene discussed is MYCN; the disease is neuroblastoma.